The preclinical pharmacology of the high affinity anti-IL-6R Nanobody® ALX-0061 supports its clinical development in rheumatoid arthritis

INTRODUCTION: The pleiotropic cytokine interleukin-6 (IL-6) plays an important role in the pathogenesis of different diseases, including rheumatoid arthritis (RA). ALX-0061 is a bispecific Nanobody® with a high affinity and potency for IL-6 receptor (IL-6R), combined with an extended half-life by ta...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Roy, Maarten, Ververken, Cedric, Beirnaert, Els, Hoefman, Sven, Kolkman, Joost, Vierboom, Michel, Breedveld, Elia, ‘t Hart, Bert, Poelmans, Sofie, Bontinck, Lieselot, Hemeryck, Alex, Jacobs, Sandy, Baumeister, Judith, Ulrichts, Hans
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4476083/
https://www.ncbi.nlm.nih.gov/pubmed/25994180
http://dx.doi.org/10.1186/s13075-015-0651-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4476083/
https://www.ncbi.nlm.nih.gov/pubmed/25994180
http://dx.doi.org/10.1186/s13075-015-0651-0

Ejemplares similares